Alison L. Hannah, Chief Medical Officer at CytomX Therapeutics, Inc. (CTMX), sold 5,602 shares at $1.42 ($8K) on 2022-07-20, disclosed to the SEC on 2022-07-21.
Open-market sale of $8k CTMX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |